Ibupas

Ibuprofen, the active ingredient in Ibupas, is a nonsteroidal anti-inflammatory drug presented as a topical gel for cutaneous use. It is used to relieve pain and reduce inflammation in adults and adolescents with musculoskeletal discomfort.

GNH USA supplies Ibupas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Ibupas (ibuprofen) acts on inflammatory pathways to provide analgesic and anti‑inflammatory effects.

- Musculoskeletal pain: alleviates aches and stiffness in muscles, tendons and joints. - Minor joint inflammation: reduces swelling and discomfort in conditions such as osteoarthritis. - Acute soft‑tissue injury: eases pain and inflammation from sprains, strains or bruises.

Topical ibuprofen may cause local and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Skin irritation: redness or mild burning at the application site. - Itching: localized pruritus. - Dryness: peeling or flaking of the skin. - Stinging sensation: transient sharp feeling upon application.

Serious or Rare Side Effects: - Allergic dermatitis: widespread rash, swelling or hives. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic toxicity: gastrointestinal ulceration or bleeding if absorbed in large amounts. - Renal impairment: reduced kidney function in susceptible individuals.

Before using Ibupas, consider the following safety measures.

- Assess medical history: confirm no known hypersensitivity to ibuprofen or other NSAIDs. - Avoid broken skin: do not apply on open wounds, cuts or irritated areas. - Limit duration: use only for the recommended short‑term period, typically up to 7 days. - Monitor gastrointestinal symptoms: watch for stomach pain, nausea or bleeding. - Caution in cardiovascular disease: evaluate risk before use in patients with heart conditions. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Ibupas may interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened ulcer risk. - Lithium: elevated lithium serum levels. - Methotrexate: enhanced methotrexate toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: potential for decreased kidney perfusion. - Selective serotonin reuptake inhibitors: modest increase in bleeding risk.